Depomed reported $26.24M in Selling and Administration Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Aerie Pharmaceuticals AERI:US $ 34.54M 1.94M
Ani Pharmaceuticals ANIP:US $ 18.82M 1.23M
Aurora Cannabis Inc ACB:CN 48.82M 1.9M
Biodelivery Sciences International BDSI:US $ 25.78M 1.98M
Cara Therapeutics CARA:US $ 5.65M 683K
Daiichi Sankyo 4568:JP 79.12B 24.69B
Depomed DEPO:US $ 26.24M 18.5M
Ironwood Pharmaceuticals IRWD:US $ 27.05M 710K
Johnson & Johnson JNJ:US $ 6.07B 641M
Knight Therapeutics Inc GUD:CN C$ 18.63M 3.94M
Merk MRK:US $ 2.25B 376M
Nektar Therapeutics NKTR:US $ 29.56M 2.12M
Omeros OMER:US $ 21.56M 3.51M
Pfizer PFE:US $ 2.79B 134M
Teva Pharmaceutical TEVA:IT 832M 16M